Advertisements


AstraZeneca"s Lynparza Gets Priority Review in 1st Line Use

AstraZeneca (AZN) and partner Merck's sNDA looking for label expansion of Lynparza in the first-line setting gets FDA's priority review. .....»»

Category: dealsSource: nytNov 13th, 2018

Tesaro, Clovis Rally on FDA Priority Review for Lynparza sNDA

PARP inhibitor makers get a boost following priority review for AstraZeneca???s (AZN) label expansion application for Lynparza as a first-line maintenance treatment for ovarian cancer. Shares of TESARO, Inc. TSRO and Clovis Oncology.....»»

Category: worldSource: nytNov 14th, 2018

AstraZeneca, Merck say Lynparza submission granted priority review in the U.S.

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 13th, 2020

AstraZeneca says Farxiga NDA granted Priority Review by FDA

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 6th, 2020

AstraZeneca says Imfinzi granted FDA Priority Review, sBLA accepted

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 29th, 2019

Merck, AstraZeneca: FDA accepts NDA, grants priority review for selumetinib

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 14th, 2019

AstraZeneca Shares Trade Higher After FDA Grants Breast Cancer Drug Priority Review

AstraZeneca plc (NYSE: AZN) and partner DAIICHI SANKYO/S ADR (OTC: DSNKY) announced positive news Thursday on their HER-2 targeting antibody drug conjugate, or ADC. read more.....»»

Category: blogSource: benzingaOct 17th, 2019

AstraZeneca says trastuzumab deruxtecan granted FDA Priority Review

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 17th, 2019

AstraZeneca agrees to buy FDA Priority Review Voucher from Sobi for $95M

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 22nd, 2019

AstraZeneca"s Lynparza approved as 1st line ovarian cancer maintenance treatment

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 18th, 2019

Pfizer"s Leukemia Candidate Gets Priority Review From FDA

The FDA grants a priority review to Pfizer's (PFE) NDA for leukemia candidate glasdegib for the first-line treatment of acute myeloid leukemia (AML) in combination with chemotherapy. Pfize.....»»

Category: personnelSource: nytJun 29th, 2018

Merck"s Keytruda Gets Priority Review in Difficult Lung Cancer

Merck's (MRK) sBLA looking to expand the label of Keytruda for first-line treatment of metastatic squamous NSCLC gets FDA's priority review. The decisio.....»»

Category: worldSource: nytJul 3rd, 2018

AstraZeneca, Merck say FDA approves Lynparza as 1st line maintenance therapy

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 19th, 2018

Merck Gets Priority Review for Keytruda Combo in Kidney Cancer

Merck's (MRK) sBLA looking for approval of Keytruda plus Pfizer's Inlyta for the first-line treatment of the most common typ.....»»

Category: personnelSource: nytFeb 18th, 2019

July luggage review: Our honest review of the trendy Australian luggage line

July makes attractive hardshell suitcases to compete with Away and Monos. We put two of its bags to the test and found they left more to be desired in packi.....»»

Category: topSource: businessinsiderApr 16th, 2024

AstraZeneca to present update on ph3 trial of LYNPARZA in early breast cancer

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 19th, 2021

Merck, Eisai receive FDA priority review for KEYTRUDA plus LENVIMA

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 6th, 2021

Calliditas Therapeutics receives priority review for Nefecon NDA from FDA

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 28th, 2021

Takeda"s Mobocertinib or TAK-788 granted FDA priority review in NSCLC treatment

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 27th, 2021

Loretto Hospital to resume distributing COVID-19 vaccines after city paused program over line-jumping allegations

City officials will again provide COVID-19 vaccines to Loretto Hospital after pausing the program last month to review allegations of dosages improperly being provided to connected people.But, the c.....»»

Category: topSource: chicagotribuneApr 17th, 2021

EMA says review of unusual blood clots and AstraZeneca COVID vaccine continues

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 31st, 2021